Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus mutans glycolytic and proton-pumping enzymes represent a critical suite of metabolic proteins that drive the pathogenesis of dental caries. The glycolytic enzymes, most notably enolase (phosphopyruvate hydratase) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), are responsible for the rapid fermentation of dietary carbohydrates into lactic acid, which lowers the local pH and demineralizes tooth enamel [1][2]. To survive this self-induced acidic environment, S. mutans employs F-type H+-ATPases (proton pumps) that actively transport protons out of the cell to maintain internal pH homeostasis [3]. These enzymes are the primary pharmacological targets of fluoride, which acts as a direct inhibitor of enolase by forming a magnesium-fluorophosphate complex and indirectly impairs the H+-ATPase by increasing membrane permeability to protons [4]. Other antimicrobial agents like chlorhexidine and stannous ions also interact with these metabolic pathways to reduce bacterial acid production [5]. Targeting these enzymes effectively reduces the virulence of S. mutans by compromising its ability to produce acid and tolerate low-pH environments [1][3]. Citations: [1] Hamilton, I. R. (1990). J Dent Res. [2] Guha-Chowdhury, N., et al. (1997). J Dent Res. [3] Matsui, R., & Cvitkovitch, D. (2010). Future Microbiol. [4] Marquis, R. E. (1995). FEMS Microbiol Rev. [5] Takahashi, N., & Nyvad, B. (2011). J Dent Res.
Inhibition of enolase activity through the formation of a metal-fluoride-phosphate complex and disruption of the F-type H+-ATPase proton pump to impair acid tolerance and metabolic activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus mutans glycolytic and proton-pumping enzymes.